{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:55:25Z","timestamp":1791644125678,"version":"4.3.4"},"reference-count":42,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,4,20]],"date-time":"2005-04-20T00:00:00Z","timestamp":1113955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clinic Periodontology"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives: <\/jats:bold> Periodontitis is believed to be an independent risk factor of cardiovascular disease (CVD) and to be associated with a moderate systemic inflammatory reaction and hyperlipidaemia. Lipoprotein\u2010associated phospholipase A<jats:sub>2<\/jats:sub> (Lp\u2010PLA<jats:sub>2<\/jats:sub>) is an enzyme that has been shown to be a risk factor of CVD and that is involved in the degradation of the phospholipid mediator platelet\u2010activating factor (PAF), a potent mediator of inflammation.<\/jats:p><jats:p><jats:bold>Material and Methods: <\/jats:bold> In the present study, we measured concentrations of plasma lipids and plasma activity of Lp\u2010PLA<jats:sub>2<\/jats:sub> in 32 patients (mean age 43\u00b111 years) with moderate\u2010to\u2010severe periodontitis before and 3 months after local treatment.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Periodontal therapy resulted in a significant reduction of local inflammation and tissue destruction as reflected in reduced pocket depths and reduced bleeding indices. Pre\u2010 and post\u2010treatment plasma lipid levels were (median and range, mmol\/l): total cholesterol (C) 5.01 (3.94\u20137.15) and 4.91 (3.32\u20138.01); low\u2010density lipoprotein\u2010cholesterol (LDL\u2010C) 3.14 (2.40\u20134.84) and 2.96 (1.39\u20135.04); HDL\u2010C 1.27 (0.73\u20132.17) and 1.25 (0.74\u20132.55); triglycerides 1.37 (0.48\u20135.11) and 1.14 (0.38\u2013792). Using the Wilcoxon's rank test, neither parameter showed a significant change. In contrast to the lacking response of plasma lipids, we observed a significant reduction in the activity of Lp\u2010PLA<jats:sub>2<\/jats:sub>. Local treatment lowered the enzyme activity by about 10% from 3.61\u00b10.99 to 3.29\u00b10.94\u2003\u03bcmol\/ml\/h (mean\u00b1SD; <jats:italic>p<\/jats:italic>&lt;0.001). The pre\u2010treatment values of Lp\u2010PLA<jats:sub>2<\/jats:sub> and LDL\u2010C significantly correlated with clinical parameters of inflammation and periodontal destruction.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> This study indicates that treatment of periodontitis significantly reduces the serum activity of Lp\u2010PLA<jats:sub>2<\/jats:sub>, which is believed to be an independent cardiovascular risk factor.<\/jats:p>","DOI":"10.1111\/j.1600-051x.2005.00725.x","type":"journal-article","created":{"date-parts":[[2005,5,10]],"date-time":"2005-05-10T01:47:43Z","timestamp":1115689663000},"page":"640-644","source":"Crossref","is-referenced-by-count":53,"title":["Lipoprotein\u2010associated phospholipase A<sub>2<\/sub> and plasma lipids in patients with destructive periodontal disease"],"prefix":"10.1111","volume":"32","author":[{"given":"W.","family":"L\u00f6sche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Marshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. F.","family":"Kinane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,4,20]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"281","article-title":"Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN)","volume":"32","author":"Ainamo J.","year":"1982","journal-title":"International Dental Journal"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345990780120301"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000116763.91992.F1"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000038145.59548.85"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300086-JLR200"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-200308000-00002"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2003.74.7.1007"},{"key":"e_1_2_5_9_1","first-page":"47","article-title":"Periodontal disease","volume":"5","author":"Cutler C. W.","year":"2003","journal-title":"Journal of the International Academy of Periodontology"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6879.688"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000085086.50957.22"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000136767.71518.36"},{"key":"e_1_2_5_13_1","unstructured":"Dohrn B.(2000)Untersuchungen zur Aktivit\u00e4t der Plasmatischen Pl\u00e4ttchen\u2010aktivierender Faktor\u2010Acetylhydrolase bei Patienten mit Sepsis.Doctoral Thesis. Medical Faculty of the Friedrich\u2010Schiller\u2010University Jena Germany."},{"key":"e_1_2_5_14_1","first-page":"289","article-title":"Platelet\u2010activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis","volume":"83","author":"Endo S.","year":"1994","journal-title":"Research Communication in Chemical Pathology and Pharmacology"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2002.73.1.73"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2000.71.10.1554"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000087144.24654.71"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2002.0377"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000051456.68470.C8"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2003.74.8.1231"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345960750090301"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2002.73.5.494"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/315611"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/003693309303800304"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2000.71.10.1528"},{"key":"e_1_2_5_26_1","first-page":"431","article-title":"Plasmalipide, Blutglucose und PAF\u2010Acetylhydrolase bei marginaler Parodontitis","volume":"55","author":"L\u00f6sche W.","year":"2000","journal-title":"Deutsche Zahn\u00e4rztliche Zeitschrift"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-051x.2000.027008537.x"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6676.779"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-2-30"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1999.277.1.R94"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2000.72.9.1221"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2000.71.6.898"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(88)90126-0"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010193431603"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.10.007"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.69.1.419"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300250-JLR200"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70266-8"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-02-0092"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(90)87041-Z"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010203"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M402454200"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0889-7204.2003.01421.x"}],"container-title":["Journal of Clinical Periodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-051X.2005.00725.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-051X.2005.00725.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:25:03Z","timestamp":1697073903000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-051X.2005.00725.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,20]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1600-051X.2005.00725.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-051x.2005.00725.x","archive":["Portico"],"relation":{},"ISSN":["0303-6979","1600-051X"],"issn-type":[{"value":"0303-6979","type":"print"},{"value":"1600-051X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,20]]}}}